Related Experiment Video

Updated: Aug 29, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

[Genetics and dilated cardiomyopathy]

E Villard1

  • 1Laboratoire de génétique et insuffisance cardiaque, Association Claude Bernard/Université Paris VI, groupe hospitalier La Pitié-Salpêtrière, pavillon Rambuteau, 47, bd de l'Hôpital, 75651 Paris. villard@chups.jussieu.fr

Archives Des Maladies Du Coeur Et Des Vaisseaux
|December 26, 2003
PubMed

Insights

Dilated cardiomyopathy involves heart muscle enlargement and dysfunction, often stemming from genetic factors or a mix of genes and environment. Identifying more genetic causes is key to better patient management.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Context:

  • Dilated cardiomyopathy (DCM) is a primary cause of heart transplantation, characterized by ventricular dilatation and dysfunction.
  • Its etiology is complex, with 70% of cases being multifactorial (genetic and environmental) and 30% monogenic (autosomal dominant).
  • A wide spectrum of genetic abnormalities and phenotypic expressions complicates DCM understanding.

Purpose:

  • To explore the genetic underpinnings of dilated cardiomyopathy.
  • To identify novel genes and understand the molecular mechanisms involved in DCM pathogenesis.
  • To enhance the management of patients and their families through improved genetic knowledge.

Summary:

  • Dilated cardiomyopathy (DCM) presents with diverse genetic causes, ranging from multifactorial influences to specific gene mutations.
  • While numerous genes linked to cardiomyocyte structure have been identified in monogenic DCM, their precise roles remain largely hypothetical.
  • Further research is needed to uncover additional disease-associated genes and elucidate the molecular and physiological pathways driving DCM.

Impact:

  • Improved diagnostic accuracy for dilated cardiomyopathy patients and their families.
  • Potential for targeted therapies based on identified genetic defects.
  • Advancement of knowledge in cardiac genetics and disease mechanisms.

More Related Videos

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish08:09

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.